- Denvax Company News Section

Denvax Information
  • Ramaknat
  • URL:
  • DENVAX is dendritic cell based cancer immunotherapy. Dendritic cells (DC) therapy delays cancer progression and improves patient survival. At ICT, they have treated a number of cancer patients with M1 (metastatic) disease who are leading a recurrence-free quality life for many months to years.
Denvax Press Release -

  • Dr. Jamal Khan's Cancer Immunotherapy Makes a Mark
  • Dr. Jamal A. Khan is a pioneer in cancer immunotherapy in India, with over seven years of exclusive clinical experience in dendritic cell therapy. His work on dendritic cell therapy in treating cancer is unparalleled in India. Dr. Jamal A. Khan has been a researcher and teaching faculty at the Jawaharlal Nehru Medical College at Aligarh Muslim University, from 1997 till 2005.
  • Given the challenges faced by millions of cancer patients, Delhi based Dr. Jamal Khan, MBBS MD; The Denvax Clinic provides a ray of hope for innumerab ...
  • April 26, 2016